soluble adenylyl cyclase inhibitors (Weill Cornell Medical College/Cornell Center for Technology Enterprise & Commercialization)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesoluble adenylyl cyclase inhibitors (Weill Cornell Medical College/Cornell Center for Technology Enterprise & Commercialization)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenylate cyclase type 10 inhibitors
TargetsAdenylate cyclase type 10
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeill Medical College of Cornell University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWeill Medical College of Cornell UniversityCornell University
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A